644 related items for PubMed ID: 15575933
1. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M, Bruce C, Sjöstrand M, Arvidsson P, Lötvall J.
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[Abstract] [Full Text] [Related]
2.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
3. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
Ravensberg AJ, Luijk B, Westers P, Hiemstra PS, Sterk PJ, Lammers JW, Rabe KF.
Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
[Abstract] [Full Text] [Related]
4. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
[Abstract] [Full Text] [Related]
5. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW.
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[Abstract] [Full Text] [Related]
6. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V, Choong L, Tran D, Corden Z, Boyce M, Arshad H, Holgate S, O'Connor B, Millet S, Miller B, Rohatagi S, Kirkesseli S.
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[Abstract] [Full Text] [Related]
7. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[Abstract] [Full Text] [Related]
8. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K, Inman MD, Watson RM, Morris MM, Efthimiadis A, Ventresca PG, Lam R, O'Byrne PM, Hargreave FE.
Can Respir J; 2000 Feb; 7(4):313-9. PubMed ID: 10980457
[Abstract] [Full Text] [Related]
9. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW.
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[Abstract] [Full Text] [Related]
10. A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness.
Bentley AM, Walker S, Hanotte F, De Vos C, Durham SR.
Clin Exp Allergy; 1996 Aug; 26(8):909-17. PubMed ID: 8877156
[Abstract] [Full Text] [Related]
11. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
Subbarao P, Dorman SC, Rerecich T, Watson RM, Gauvreau GM, O'Byrne PM.
J Allergy Clin Immunol; 2005 Apr; 115(4):745-50. PubMed ID: 15805993
[Abstract] [Full Text] [Related]
12. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Proprionate Clinical Research Study Group.
J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
[Abstract] [Full Text] [Related]
13. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
Koopmans JG, Lutter R, Jansen HM, van der Zee JS.
J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
[Abstract] [Full Text] [Related]
14. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ.
Am J Respir Crit Care Med; 2003 May 01; 167(9):1232-8. PubMed ID: 12456382
[Abstract] [Full Text] [Related]
15. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I, Woodcock A, Parker D, Rice L, SOLTA study group.
Respir Res; 2007 Sep 27; 8(1):67. PubMed ID: 17897478
[Abstract] [Full Text] [Related]
16. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
Diamant Z, Van der Veen H, Kuijpers EA, Bakker PF, Sterk PJ.
Clin Exp Allergy; 1996 May 27; 26(5):525-32. PubMed ID: 8735864
[Abstract] [Full Text] [Related]
17. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
Peroni D, Bodini A, Miraglia Del Giudice M, Loiacono A, Baraldi E, Boner AL, Piacentini G.
Allergy; 2005 Feb 27; 60(2):206-10. PubMed ID: 15647042
[Abstract] [Full Text] [Related]
18. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
O'Sullivan S, Akveld M, Burke CM, Poulter LW.
Am J Respir Crit Care Med; 2003 Mar 01; 167(5):745-50. PubMed ID: 12480610
[Abstract] [Full Text] [Related]
19. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA, Seidenberg BC, Zwinderman AH, Peszek I, Sterk PJ.
Clin Exp Allergy; 1999 Jan 01; 29(1):42-51. PubMed ID: 10051701
[Abstract] [Full Text] [Related]
20. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Ostrom NK, Decotiis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza Rosenzweig JR, Crim C.
J Pediatr; 2005 Aug 01; 147(2):213-20. PubMed ID: 16126052
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
